Seratrials: Biological Samples Collection About the study? PROSPECTIVE COLLECTION OF CEREBRAL SPINAL FLUID (CSF), WHOLE BLOOD, NASAL SWABS, URINE AND SALIVA SAMPLES FROM SUBJECTS DIAGNOSED WITH OR SUSPECTED TO HAVE NEUROLOGICAL DISORDERS, COGNITIVE IMPAIRMENT, OR INFECTIONS OF CSF AND NORMAL CONTROLS FOR RESEARCH Purpose of the study? SeraTrials is a biotechnology company that partners with […]
Biohaven BHV7000 Rise Focal Epilepsy Study About the study? Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems. Purpose of the study? The goal of this clinical trial is to is to test whether Walkasins can help people with peripheral neuropathy maintain their balance better. The main question it aims to
RxFunction Balance4Mobility: Walkasin’s Device Read More »
Biohaven BHV7000 Rise Focal Epilepsy Study About the study? A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety, and Tolerability of BHV-7000 in Subjects with Refractory Focal Onset Epilepsy. Purpose of the study? If you or a loved one have been diagnosed with focal onset epilepsy, are between the ages of
Biohaven BHV7000 Rise Read More »
Praxis Power2 study for Focal Epilepsy About the study? A Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults with Focal Seizures. Purpose of the study? The main purpose of this research is to see how well vormatrigine works for treating focal onset seizures compared with placebo, as well as its
Praxis Power2 study Read More »
ARGENX Platform trial About this clinical research study: Adapt Forward is a platform of studies designed for people living with MG. It consists of several studies that are meant to evaluate how different combinations and regimens of MG drugs may work (also known as efficacy) and how safe they are for the use in adults
ARGENX Platform trial Read More »
ANNOVIS Alzheimer’s Disease What is the ANNOVIS Alzheimer’s Disease Study? A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD The Goal The goal of this clinical trial is to learn if buntanetap/Posiphen works to treat early Alzheimer’s disease in adults aged 55-85. It will also learn about the safety
ANNOVIS Alzheimer’s Disease Read More »
Roche/Genentech PARAISO Why is the study needed? Paraiso is study to compare prasinezumab with a placebo in people with early-stage Parkinson’s disease who are taking levodopa to manage their disease symptomsParkinson’s disease (PD) is a long-term condition that gets worse over time. In PD, a naturally occurring protein called alpha-synuclein does not form properly. It sticks together
Roche/Genentech PARAISO Read More »
Cartesian Aurora What is the AURORA Study? The aim of the AURORA Study is to assess the safety and effectiveness of an mRNA CAR T-cell therapy, known as Descartes-08, as a potential approach to treat generalized myasthenia gravis. Myasthenia gravis is an autoimmune disease, which means that the immune system mistakenly produces antibodies (proteins that
Novartis “Relieve” We are assessing the effectiveness and safety of remibrutinib, an investigational medicine being developed for people who have generalized Myasthenia Gravis (gMG). Click here for More Information Inclusion Criteria: – Have a confirmed, documented diagnosis of gMG: either positive for AChR+ antibody or MuSK+ antibody, or seronegative for both AChR and MuSK antibodies
Novartis “Relieve” Read More »
ArgenX Empassion The Empassion study is designed to assess how safe and effective an investigational study drug, empasiprubart, is compared to intravenous immunoglobulin (IVIg) as a possible treatment for adults living with multifocal motor neuropathy (MMN). The clinical study is looking to enroll up to 100 participants across the world. Enrolled participants will be asked
